To the content
3 . 2020

Cardiovascular diseases in Central and Eastern Europe: a call for more surveillance and evidence-based health promotion

Abstract

The paper aims to identify the priorities for cardiovascular health promotion research in Central and Eastern Europe (CEE), the region with the highest cardiovascular diseases (CVD) burden in the world.

Methods. This narrative review covered peer-reviewed publications and online databases using a nonsystematic purposive approach.

Results. In despite of a steady decrease in CVD burden in the region, the East-West disparities are still significant. There is minimal continuity in the past and current CVD prevention efforts in the region. Many challenges still exist, including an opportunity gap in research funding, surveillance and population-based preventive interventions. A comprehensive approach focusing on multisectoral cooperation, quality and accessibility of healthcare and equity-oriented public policies and supported by well-designed epidemiologic studies is needed to overcome these challenges.

Conclusion. The current level of effort is not adequate to address the magnitude of the CVD epidemic in CEE. It is imperative to strengthen the epidemiological base concerning cardiovascular health in the region, to foster surveillance and progress in implementation of CVD preventive strategies in the most affected populations of Europe.

Funding. This work was supported by the National Program of Sustainability II (MEYS CR) (no. LQ1605), and by the European Regional Development Fund - Project ENOCH (No. CZ.02.1.01/0.0/0.0/16_019/0000868).

Competing Interests. The Authors declared no conflict of interest, all authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. All authors contributed to this work.

Литература/References

1. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016; 37 (42): 3232-45. DOI: https://doi.org/10.1093/eurheartj/ehw334.

2. European Cardiovascular Disease Statistics 2017. European Heart Network Brussels, 2017.

3. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation. 2015; 132 (17): 1667-78. DOI: https://doi.org/10.1161/CIRCULATI0NAHA.114.008720

4. The contributions of risk factor trends and medical care to cardiovascular mortality trends. Nat Rev Cardiol. 2015; 12 (9): 508-30. DOI: https://doi.org/10.1038/nrcardio.2015.82.

5. Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. Eur Heart J. 2006; 27 (1): 107-13. DOI: https://doi.org/10.1093/eurheartj/ehi511.

6. Health in the European Union - facts and figures. Online publications 2017. URL; http://ec.europa.eu/eurostat/statistics-explained/index.php/Health_in_the_European_Union_%E2%80%93_facts_and_figures. (date of access February 26, 2018)

7. East-West mortality divide and its potential explanations: proposed research agenda. BMJ. 1996; 312(7028): 421-5. DOI: https://doi.org/10.1136/bmj.312.7028.421.

8. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet. 2000; 355 (9205): 67587. DOI: https://doi.org/10.1016/S0140-6736(99)11180-2.

9. Trends in mortality from ischemic heart disease and cerebrovascular disease in Europe: 1980 to 2009. Circulation. 2016; 133 (20): 1916-26. DOI: https://doi.org/10.1161/CIRCULATIONAHA.115.018931.

10. Coronary heart disease policy models: a systematic review. BMC Public Health. 2006; 6: 213. DOI: https:// doi.org/10.1186/1471-2458-6-213.

11. Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000. Am J Public Health. 2010; 100 (4): 684-92. DOI: https://doi.org/10.2105/AJPH.2008.147173.

12. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004; 109 (9): 1101-7. DOI: https://doi.org/10.1161/01.CIR.0000118498.35499.B2.

13. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol. 2005; 162 (8): 764-73. DOI: https://doi.org/10.1093/aje/kwi274.

14. Explaining the decline in coronary heart disease mortality in the Czech Republic between 1985 and 2007. Eur J Prev Cardiol. 2014; 21 (7): 829-39. DOI: https://doi.org/10.1177/2047487312469476.

15. Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study. BMJ. 2012; 344: d8136. DOI: https://doi.org/10.1136/bmj.d8136.

16. The epidemiological transition in Eastern and Western Europe: a historic natural experiment. Eur J Public Health. 2017; 27: 4-8. DOI: https://doi.org/10.1093/eurpub/ckx158

17. Ischaemic heart disease in the former Soviet Union 1990-2015 according to the Global Burden of Disease 2015 Study. Heart. 2018; 104 (1): 58-66. DOI: https://doi.org/10.1136/heartjnl-2016-311142.

18. Changes in premature deaths in Finland: successful long-term prevention of cardiovascular diseases. Bull World Health Organ. 1998; 76 (4): 419-25.

19. Assessing risk for coronary heart disease: beyond Framingham. Am Heart J. 2003. 146 (4): 572-80. DOI: https://doi.org/10.1016/S0002-8703(03)00500-3.

20. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Prev Cardiol. 2016; 23 (11): NP1-96.

21. Alcohol, drinking pattern and all-cause, cardiovascular and alcohol-related mortality in Eastern Europe. Eur J Epidemiol. 2016; 31 (1): 21-30. DOI: https://doi.org/10.1007/s10654-015-0092-8.

22. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardio- metabolic risk factors between 1980 and 2010: Comparative risk assessment. Lancet Diabetes Endocrinol. 2014; 2 (8): 634-47. DOI: https://doi.org/10.1016/S2213-8587(14)70102-0.

23 Stefler D., Bobak M. Does the consumption of fruits and vegetables differ between Eastern and Western European populations? Systematic review of cross-national studies. Arch Public Health (Archives Belges de Sante Pub-lique). 2015; 73 (1): 29-9. DOI: https://doi.org/10.1186/s13690-015-0078-8.

24. Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet. 2012; 380 (9838): 247-57. DOI: https://doi.org/10.1016/S0140-6736(12)60646-1.

25. Alcohol increases circulatory disease mortality in Russia: acute and chronic effects or misattribution of cause? Int J Epidemiol. 2010; 39 (5): 1279-90. DOI: https://doi.org/10.1093/ije/dyq102.

26. From cardiovascular disease to cardiovascular health: a quiet revolution? Circ Cardiovasc Qual Outcomes. 2012; 5(6): e86-92. DOI: https://doi.org/10.1161/CIRCOUTCOMES.111.964726

27. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010; 121 (4): 586-613. DOI: https://doi.org/10.1161/CIRCULATIONAHA.109.192703.

28. The Pursuit of Ideal Cardiovascular Health: An Individual and Societal Challenge. Mayo Clin Proc. 2012; 87 (10): 929-31. DOI: https://doi.org/10.1016/j.mayocp.2012.08.008.

29. Using the concept of ideal cardiovascular health to measure population health: a review. Curr Opin Cardiol. 2015; 30 (5): 518-24. DOI: https://doi.org/10.1097/HCO.0000000000000210.

30. Global cardiovascular health promotion and disease prevention: 2011 and beyond. Circulation. 2012; 125 (21): 2667-76. DOI: https://doi.org/10.1161/CIRCULA-TIONAHA.111.087726

31. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed). 1981; 282 (6279): 1847

51. DOI: https://doi.org/10.1136/bmj.282.6279.1847.

32. Reflections on cardiovascular diseases. Inter-discip Sci Rev. 1978; 3(3): 225-30. DOI: https://doi.org/10.1179/030801878791925921.

33. The unequal health of Europeans: successes and failures of policies. Lancet. 2013; 381 (9872): 1125-34. DOI: https://doi.org/10.1016/S0140-6736(12)62082-0.

34. Are WHO "best buys" for non-communicable diseases effective in low-income and lower-middle-income countries? A systematic review. Lancet Global Health. 2017; 5 (1): S17. DOI: https://doi.org/10.1016/S2214-109X(17)30124-9.

35. Implementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries: an association study. Lancet Public Health. 2017; 2 (4): e166-74. DOI: https://doi.org/10.1016/S2468-2667(17)30045-2.

36. NCD Countdown 2025: accountability for the 25 x 25 NCD mortality reduction target. Lancet. 2014; 384 (9938): 105-7. DOI: https://doi.org/10.1016/S0140-6736(14)61091-6.

37. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev. 2011; 1: CD001561. DOI: https://doi.org/10.1002/14651858.CD001561.pub3.

38. Merzel C., D'Afflitti J. Reconsidering community-based health promotion: promise, performance, and potential. Am J Public Health. 2003; 93 (4): 557-74. DOI: https://doi.org/10.2105/AJPH.93.4.557.

39. WHO MONICA project: what have we learned and where to go from here? Public Health Rev. 2011; 33: 37396. DOI: https://doi.org/10.1007/BF03391642.

40. A strategy to prevent chronic disease in Europe. A focus on public health action: The CINDI vision. Copenhagen, 2004.

41. American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers. Circulation. 2013; 127 (16): 1730-53. DOI: https://doi.org/10.1161/CIR.0b013e31828f8a94.

42. Trends in coronary risk factors in the WHO MONICA project. Int J Epidemiol. 2001; 30: S35-40. DOI: https://doi.org/10.1093/ije/30.suppl_1.S35.

43. Health law and policy in the European Union. Lancet. 2013; 381 (9872): 1135-44. DOI: https://doi.org/10.1016/S0140-6736(12)62083-2.

44. Health reform in central and eastern Europe and the former Soviet Union. Lancet. 2009; 374 (9696): 1186-95. DOI: https://doi.org/10.1016/S0140-6736(09)61334-9.

45. Public Health Education in Central and Eastern Europe, and Central Asia. Public Health Rev. 2011; 33: 10533. DOI: https://doi.org/10.1007/BF03391623.

46. Fifty years of serving public health: the Association of Schools of Public Health in the European Region moving forward to the next half-century. Int J Public Health. 2016; 61 (6): 631-2. DOI: https://doi.org/10.1007/s00038-016-0824-x.

47. Tobacco and transition: an overview of industry investments, impact and influence in the former Soviet Union. Tobacco Control. 2004; 13 (2): 136-42. DOI: https://doi.org/10.1136/tc.2002.002667.

48. How has the management of acute coronary syndrome changed in the Russian Federation during the last 10 years? Health Policy. 2017; 121 (12): 1274-9. DOI: https://doi.org/10.1016/j.healthpol.2017.09.018.

49. The significance and impact of the Polish Anti-Tobacco Law. J Health Inequal. 2016; 2 (1): 32-5. DOI: https://doi.org/10.5114/jhi.2016.61417.

50. Comprehensive program for the prevention of noncommunicable diseases: planning, implementation and evaluation. J Prev Med. 2012; 1.51. The recent mortality decline in Russia: beginning of the cardiovascular revolution? Popul. Dev. Rev. 2014; 40 (1): 107-29. DOI: https://doi.org/10.1111/j.1728-4457.2014.00652.x.

52. Health indicators in Europe: availability and data needs. Eur J Public Health. 2012; 22 (5): 716-21. DOI: https://doi.org/10.1093/eurpub/ckr195.

53. European Society of Cardiology: Registries & Surveys. 2018. URL: https://www.escardio.org/Research/Reg-istries-&-surveys/Participate-in-a-registry. (date of access March 7, 2018)

54. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol. 2019; 26 (8): 824-35. DOI: https://doi.org/10.1177/2047487318825350.

55. Psychosocial and socioeconomic determinants of cardiovascular mortality in Eastern Europe: a multicentre prospective cohort study. PLoS Med. 2017; 14 (12): e1002459. DOI: https://doi.org/10.1371/journal.pmed.1002459.

56. Socioeconomic inequalities in all-cause mortality in the Czech Republic, Russia, Poland and Lithuania in the 2000s: findings from the HAPIEE Study. J Epidemiol Community Health. 2014; 68 (4): 297-303. DOI: https://doi.org/10.1136/jech-2013-203057.

57. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low, middle, and high-income countries. Am Heart J. 2009; 158 (1): 1-7.e1. DOI: https://doi.org/10.1016/j.ahj.2009.04.019.

58. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet. 2017; 390 (10 107): 2050-62.

59. Kardiovize Brno 2030, a prospective cardiovascular health study in Central Europe: methods, baseline findings and future directions. Eur J Prev Cardiol. 2018; 25 (1): 54-64. DOI: https://doi.org/10.1177/2047487317726623

60. Association of dietary patterns with metabolic syndrome: results from the Kardiovize Brno 2030 Study. Nutrients. 2018; 10 (7): 898. DOI: https://doi.org/10.3390/nu10070898

61. Prevalence of ideal cardiovascular health in a Central European community: results from Kardiovize Brno 2030. In: EuroPrevent. Ljubjana, Slovenia, 2018. DOI: https://doi.org/10.1177/2047487319834875

62. Mapping health research capacity in 17 countries of the former Soviet Union and southeastern Europe: an exploratory study. Eur J Public Health. 2016; 26 (2): 349-54. DOI: https://doi.org/10.1093/eurpub/ckv186

63. Chronic Non-Communicable Diseases Research Activities and their Impact: Final Report. European Commission, Community Research and Development Information Service (CORDIS), 2015. URL: http://cordis.europa.eu/re-sult/rcn/184843_en.html.

64. Towards a comprehensive global approach to prevention and control of NCDs. Global. Health. 2014; 10: 74. DOI: https://doi.org/10.1186/s12992-014-0074-8.

65. The prevention paradox or the inequality paradox? Eur J Public Health. 2008; 18 (3): 215. DOI: https://doi.org/10.1093/eurpub/ckn048.

66. Chronic disease research in Europe and the need for integrated population cohorts. Eur J Epidemiol. 2017; 32 (9): 741-9. DOI: https://doi.org/10.1007/s10654-017-0315-2.

CHIEF EDITOR
CHIEF EDITOR
Guzel E. Ulumbekova
MD, MBA from Harvard University (Boston, USA), Head of the Graduate School of Healthcare Organization and Management (VSHOUZ)
РОСМЕДОБР 2021
Вскрытие
Medicine today

Уважаемые коллеги! Приглашаем Вас принять участие в VI Научно-практической конференции "Парадигмы лекарственной терапии у онкологических больных" ( https://mrrcconference.ru/ ), которая впервые состоится в Москве, в очном формате 08-09 сентября 2022 г. Адрес : г. Москва, ул...

XI Национальный конгресс с международным участием имени Н.О. Миланова "Пластическая хирургия, эстетическая медицина и косметология" - Реконструкция формы. Управление временем С 29 ноября по 1 декабря 2022 года в Москве пройдет XI Национальный конгресс "Пластическая хирургия,...

15-17 сентября на площадке "Рэдиссон Славянская Отель и Бизнес-центр" в Москве состоится XIII международный форум "Росмедобр-2022. Инновационные обучающие технологии в медицине" - крупнейшее ежегодное событие в сфере медицинского образования в русскоязычном пространстве....


Journals of «GEOTAR-Media»